Subcutaneous (SQ) injection: A small injection just under the skin may be used in regenerative protocols to enhance deeper repair and collagen remodeling
The studies tested various doses including 0.25 mg, 0.5 mg, and 1 mg daily via subcutaneous administration over periods ranging from single doses to 24 weeks of continuous therapy
Oral, sublingual, and injectable forms absorb differently, affecting how well they work
Prescriptions are sent in one-month supplies to allow for adjustment of doses as you advance in your treatment plan
This peptide therapy may be incorporated into personalized wellness programs under provider supervision
Tirzepatide engages GIP near the strength of the natural hormone but activates GLP-1 about 18 times more weakly than natural GLP-1. After accounting for protein binding in blood, the drug is roughly 20-fold GIP-forward and has no meaningful glucagon activity